0
GSK
GSK PLC ADR · Health Care
Consensus score 0/100 · #306 this quarter · tier-weighted across tracked managers
→NeutralPrice action since filingas of 2026-06-05
vs 50-day avg
-3.4%
21-day momentum
+2.0%
recent volume
0.84×
13F filings lag ~45 days; this is current price/volume action on top — a technical read, not a prediction.
S3· ToppingStage Analysis · Weinstein
vs 30-wk avg
-1.1%
30-wk MA slope
+1.8%
rel. strength
-3.5
52-wk range
61%
Topping — momentum stalling at the highs; distribution risk. Based on the 30-week (150-day) moving average + slope, Mansfield relative strength vs SPY, and volume. Technical read, not advice.
Holders
2
tracked managers
New this Q
0
opened a position
Avg weight
0.2%
of their portfolios
Combined value
$6M
held, at quarter-end
Who’s holding it Q1 2026, by position size
| Manager | Position size | Value | Change |
|---|---|---|---|
| Tweedy Browne Graham/global value | 0.4% | $5M | TRIM |
| Horizon Kinetics Franchise/inflation | 0.0% | $1M | TRIM |
Position size = share of that manager’s reported long US-equity portfolio. The consensus score weights each holder by quality tier, position size, and whether they were buying or trimming — then discounts very crowded names. It measures agreement among these managers, not expected return.